KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Accumulated Expenses (2016 - 2026)

Chemed filings provide 18 years of Accumulated Expenses readings, the most recent being $62.8 million for Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses rose 4.75% year-over-year to $62.8 million, compared with a TTM value of $62.8 million through Mar 2026, up 4.75%, and an annual FY2025 reading of $58.3 million, down 36.65% over the prior year.
  • Accumulated Expenses hit $62.8 million in Q1 2026 for Chemed, up from $58.3 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $92.1 million in Q4 2024, with the low at $49.8 million in Q1 2024.
  • Median Accumulated Expenses over the past 5 years was $68.3 million (2022), compared with a mean of $69.5 million.
  • The largest YoY upside for Accumulated Expenses was 20.29% in 2025 against a maximum downside of 36.65% in 2025.
  • Year by year, Accumulated Expenses stood at $87.4 million in 2022, then rose by 1.18% to $88.4 million in 2023, then increased by 4.18% to $92.1 million in 2024, then plummeted by 36.65% to $58.3 million in 2025, then rose by 7.58% to $62.8 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $62.8 million, $58.3 million, and $79.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.